Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
101 hedge funds and large institutions have $318M invested in Taro Pharmaceutical Industries Ltd. in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 14 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 27
4% less funds holding
Funds holding: 105 → 101 (-4)
9% less capital invested
Capital invested by funds: $351M → $318M (-$32.3M)
14% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 14
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$4.48M |
| 2 |
CM
Crestline Management
Fort Worth,
Texas
|
+$3M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$2.9M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$2.55M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SGA
Strategic Global Advisors
Newport Beach,
California
|
-$6.27M |
| 2 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$4.2M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$1.93M |
| 4 |
Morgan Stanley
New York
|
-$1.53M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
-$1.2M |
TARO Hedge Fund Activity: Q3 2019 in Review
101 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q3 2019, worth a combined $318M — down 9.2% from $351M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of TARO and 12 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 36 added.
The largest buyer was Millennium Management, adding an estimated $4.48M. The largest seller was Strategic Global Advisors, exiting entirely with an estimated $6.27M sold.
- 101 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q3 2019, down from 105 in Q2 2019.
- Funds reported $318M of Taro Pharmaceutical Industries Ltd. stock for Q3 2019, down 9.2% quarter-over-quarter.
- 12 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q3 2019 and 14 closed out, a net change of -2 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q3 2019 was Millennium Management, an estimated $4.48M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q3 2019 was Strategic Global Advisors, an estimated $6.27M sold.
Based on aggregated 13F filings for Q3 2019.